Key Takeaways

• CVS Health stock closed at $79.96 on 4 November 2026, about 12.53% below the prior close, after touching an intraday low of $77.33.
• The fall came on the day CVS Health reported Q3 adjusted EPS of $2.09 against a $1.65 consensus and raised 2026 adjusted EPS guidance to at least $8.20.
• CVS Health plans to separate its retail pharmacies from Aetna, Caremark, and its care-delivery units, with completion expected in the first half of 2028.

CVS stock gave back about 12.53% on Wednesday and closed at $79.96, on the same day CVS Health Corporation (NYSE:CVS) beat third-quarter earnings forecasts by 44 cents a share and raised its full-year guidance. ^1,2 Prices are as of 10:06 (GMT+8) on 5 November 2026, read from the NYSE chart used for this analysis.

A beat-and-raise followed by a double-digit fall is the gap this piece unpacks: what the market appeared to price instead of the quarter, what the hourly CVS stock chart showed, and what changes for CVS share CFD traders. For anyone holding exposure overnight, the first problem was the gap itself, which opened the session well below Tuesday’s levels.

As of 10:06 (GMT+8) on 5 November 2026, CVS Health last closed at $79.96 on the NYSE, down about 12.53% from a prior close near $91.41, and the overnight quote on the chart stood at $80.59. The prior close is derived from 24/7 Wall St.’s mid-morning print of $81.33, which it reported as an 11.03% fall. ³

A Beat and Raise, Then a Breakup

On the numbers alone, CVS earnings gave the share price little to argue with. In its third-quarter results, revenue rose 5.4% to $108.4 billion, adjusted earnings per share (EPS) came in at $2.09, and 2026 adjusted EPS guidance moved to at least $8.20 from $7.90 to $8.10. ¹ Against the $1.65 consensus compiled by LSEG, that beat was 26.67%, and CEO David Joyner noted it was the eighth straight quarter ahead of Wall Street expectations. ²

The same morning brought the bigger change. CVS Health plans to split into two publicly traded companies. ⁵ One keeps the CVS Health name under Joyner and holds Aetna, Caremark, CVS Specialty, Oak Street Health, and Signify Health. The other, CVS Pharmacy, takes about 9,000 stores and MinuteClinic, with completion expected in the first half of 2028. ⁵

In CVS stock premarket trading, Reuters reported the shares 0.4% higher early on. ⁴ By the cash open, the first hourly bar traded no higher than about $87.60.

The quarter explains why CVS Health stock could have risen. It does not explain a 12.53% fall.

What the CVS Stock Fall Appeared to Price

Analyst comments on the day pointed to the split’s missing price tag. Barclays analyst Andrew Mok named the lack of financial detail around the breakup as the main investor concern, recalling that CVS attached at least $500 million of synergies to its Caremark deal two decades ago. ² No matching estimate of dis-synergies came with this announcement.

Chief Financial Officer Brian Newman said on the call that the strategic value of the separation should outweigh any dis-synergies, and that more detail would follow as the process advances. ⁶ UBS analyst Kevin Caliendo said the split was “perceived as happening as a defensive move against regulation”. ²

Unwinding CVS is closer to rerouting a shared supply line than to splitting a bill. Caremark, Aetna, and the stores trade with each other inside one company today; after 2028, CVS says, those flows would run through commercial agreements between two companies. ⁵

The second weight was 2027. CVS guided to adjusted EPS of at least $8.65, above the $8.53 consensus, but Newman flagged pressure on the pharmacy benefit business from the federal 340B drug discount programme, a less robust selling season, and declining health plan membership. ² Management also described 2027 as a trough year for the Health Services segment. ⁶

Anyone who followed the August report may recognise the shape of this reaction.

The Second Beat-and-Fade in Three Months

On 5 August 2026, CVS beat second-quarter estimates, raised guidance, and offered a first 2027 view of at least $8.44 a share; the stock fell 5.1% that day. ⁷ On 4 November the 2027 floor rose by 21 cents to at least $8.65, and the stock fell more than twice as far.

In both sessions the quarter just reported was strong, and the share price moved on what the release said about later: first a 2027 figure in line with consensus, then a structural change with no cost estimate attached.

The fall also looked specific to CVS rather than to the sector. The Health Care Select Sector SPDR Fund (XLV), where CVS held a 2.30% weight as of 30 June, was still 0.86% higher by mid-morning on Wednesday, a day when the wider stock market also traded higher. ³

In both August and November, CVS beat and raised, and in both sessions the stock fell on what the release said about the future rather than the quarter in hand.

That is the fundamental read. The hourly CVS stock chart shows how the repricing played out.

What the Hourly CVS Stock Chart Shows

The first hourly bar on 4 November topped out near $87.60, already well under Tuesday’s close near $91.41, and its lower wick reached the session low of $77.33. ³ The remaining six hourly bars held a band of roughly $79.40 to $81.80 before the session closed at $79.96, the CVS stock price at the cut-off.

The two moving averages on the chart sat near $89.02 and $89.35 at the cut-off, about 11% above the close. The faster line had just turned down through the slower one, which is what averages do when asked to absorb a 12.53% gap in one sitting.

The 14-period Relative Strength Index (RSI) on the TradingView setup used for this analysis read 23.31 at the cut-off, after dipping to about 20 straight after the gap, the lowest reading in the chart’s four-week window. Oversold describes the indicator’s reading, not what price does next.

Table 1: CVS Stock Levels Traders Are Watching, as of 10:06 (GMT+8) on 5 November 2026

Level	Price (approx.)	What happened there
Prior close, 3 November	$91.41 (derived)	Last close before the results and split announcement
Moving average zone	$89.02 to $89.35	50- and 200-period hourly averages at the cut-off
2 to 3 November lows	$88.00	Where the hourly bars found a floor before the announcement
First-hour high, 4 November	$87.60	Highest print of the gap session
Post-gap band	$79.40 to $81.80	Range of the last six hourly bars on 4 November
Session low, 4 November	$77.33	Intraday low reported by 24/7 Wall St. 3

Source: NYSE:CVS hourly chart on TradingView and 24/7 Wall St., ³ accessed on 5 November 2026. Chart-read levels are approximate.

Levels show where price has been. The calendar shows when the missing information may arrive.

What to Watch Next for CVS Stock

• Q4 2026 Results, On or Around 8 February 2027: Trefis expects full 2027 guidance on this call; the date is not confirmed. ⁷
• Form 10 Filing, Date Not Yet Set: The separation needs an effective Form 10 registration, final board approval, and tax confirmation, according to the company’s quarterly filing. ⁸
• Dividend Declaration, Early January 2027 (Based on Past Timing): CVS paid $0.665 a share on 2 November 2026, ⁹ and its last January declaration came on 6 January 2026. ¹⁰
• 340B and Caremark Updates, Ongoing: Any figure sizing the 2027 pharmacy benefit headwinds analysts flagged. ²

This read weakens if CVS publishes a dis-synergy estimate and the share price barely reacts; it holds while that cost stays unquantified.

Wednesday’s contradiction resolves this way: the quarter was strong, but CVS stock appeared to be repriced on the two things the release could not yet measure, the cost of the split and the shape of 2027. Until those numbers arrive, the beat-and-raise has not settled the read.

Gap Risk and Leverage on CVS Share CFDs

The 4 November session showed how far a share CFD can open from the prior close. A Stop Loss order is designed to limit losses to a planned size, but when the market gaps, as CVS did from about $91.41 to a first-hour high near $87.60, the order may be filled at the first available price rather than the level set. CVS share CFDs follow US trading hours, which run overnight for traders in Asia (GMT+8), so news released before the US open can arrive as a gap at the next session.

Leverage cuts both ways and magnifies losses as well as gains. Under FCA rules, leverage on share CFDs such as CVS is capped at 1:5 for retail clients; at that ratio, a 12.53% move in the underlying equals about 63% of the margin posted. Sizing positions as a percentage of account equity, rather than as a number of shares, makes the effect of a gap this size easier to measure against the account balance before it happens.

CVS Stock FAQ

Why is CVS stock down?

CVS stock fell about 12.53% on 4 November 2026 after CVS Health announced a plan to split into two companies alongside its Q3 earnings beat. Analysts cited missing financial detail on the split and 2027 pharmacy benefit headwinds. ²

What is the CVS ticker symbol?

CVS Health trades on the New York Stock Exchange under the CVS stock symbol, and the Vantage share CFD uses the same ticker. Three letters, one company, at least until the planned 2028 separation.

Did the split announcement change the CVS dividend?

CVS paid a quarterly dividend of $0.665 a share on 2 November 2026. ⁹ Dividend policy for each company after the separation has not been set out, and 24/7 Wall St. expects it to appear in the Form 10 filing. ³

RISK WARNING: CFDs are complex financial instruments and carry a high risk of losing money rapidly due to leverage. You should ensure you fully understand the risks involved and carefully consider whether you can afford to take the high risk of losing your money before trading.

Disclaimer: The information is provided for educational purposes only and doesn’t take into account your personal objectives, financial circumstances, or needs. It does not constitute investment advice. We encourage you to seek independent advice if necessary. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research. No representation or warranty is given as to the accuracy or completeness of any information contained within. This material may contain historical or past performance figures and should not be relied on. Furthermore estimates, forward-looking statements, and forecasts cannot be guaranteed. The information on this site and the products and services offered are not intended for distribution to any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

References

[1] “CVS Health Corporation reports third quarter 2026 results and raises full-year 2026 guidance – CVS Health” https://www.cvshealth.com/news/company-news/cvs-health-corporation-reports-third-quarter-2026-results-and-raises-full-year-2026-guidance.html Accessed on 5 November 2026.

[2] “CVS shares plunge 13% after surprise plan to split company – Honolulu Star-Advertiser (Reuters)” https://www.staradvertiser.com/2026/11/04/breaking-news/cvs-shares-plunge-13-after-surprise-plan-to-split-company/ Accessed on 5 November 2026.

[3] “CVS Is Breaking Itself Up. Here’s What That Means for Your Healthcare ETF – Yahoo Finance (24/7 Wall St.)” https://finance.yahoo.com/healthcare/articles/cvs-breaking-itself-means-healthcare-163317438.html Accessed on 5 November 2026.

[4] “CVS Health to split in two, separating pharmacy business from insurance – Investing.com (Reuters)” https://investing.com/news/stock-market-news/cvs-health-to-split-in-two-separating-pharmacy-business-from-insurance-4998559 Accessed on 5 November 2026.

[5] “CVS to split into 2 companies – Becker’s Payer Issues” https://www.beckerspayer.com/financial/cvs-to-split-into-2-companies/ Accessed on 5 November 2026.

[6] “Earnings call transcript: CVS Health beats Q3 2026 estimates, shares fall premarket – Investing.com” https://ca.investing.com/news/stock-market-news/earnings-call-transcript-cvs-health-beats-q3-2026-estimates-shares-fall-premarket-93CH-4930327 Accessed on 5 November 2026.

[7] “What Could Stop CVS Health Stock Over The Next Six Months? – Trefis” https://www.trefis.com/articles/619735/what-could-stop-cvs-health-stock-over-the-next-six-months/2026-10-21 Accessed on 5 November 2026.

[8] “CVS Health Corporation Form 10-Q, Quarter Ended 30 September 2026 – US Securities and Exchange Commission” https://www.sec.gov/Archives/edgar/data/0000064803/000006480326000108/cvs-20260930.htm Accessed on 5 November 2026.

[9] “CVS Health declares quarterly dividend – Placera (PR Newswire)” https://www.placera.se/pressmeddelanden/cvs-health-declares-quarterly-dividend-20260930 Accessed on 5 November 2026.

[10] “CVS Health declares quarterly dividend – CVS Health Investor Relations” https://investors.cvshealth.com/news/news-details/2026/CVS-Health-declares-quarterly-dividend/default.aspx Accessed on 5 November 2026.